MedTrace Logo

The Association of hsCRP and Radiotherapy-Induced Toxicity in Patients With Nasopharyngeal Carcinoma

NCT04303975 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2020-06-11

No results posted yet for this study

Summary

The primary purpose of this study is to explore the association of high sensitivity C-reactive protein (hsCRP) and radiotherapy(RT)-induced toxicity in patients with nasopharyngeal carcinoma. In each patient, hsCRP levels in the pre- and post-RT plasma samples will be measured according to the schedule we set.

Conditions

Interventions

OTHER

clinical measurements

Only clinical parameters were recorded, no intervention was made.

Sponsors & Collaborators

  • Jiarong Chen, MD

    lead OTHER

Principal Investigators

  • Jiarong Chen, PhD · Affiliated Jiangmen Hospital of Sun Yat-Sen University

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-30
Primary Completion
2021-12-31
Completion
2021-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04303975 on ClinicalTrials.gov